John George, Glaxo begins Web data system, Philadelphia Business Journal, September 2, 2004. Excerpt: "GlaxoSmithKline said Wednesday it has posted the first set of data on its GSK Clinical Trial Register, a Web site that eases access to information derived from company-sponsored clinical trials. The register will provides summary results of GSK-sponsored trials of the company's marketed medicines. It also notes references to related publications that have appeared in the medical literature....In June, New York Attorney General Eliot Spitzer sued GSK, accusing the pharmaceutical company of concealing studies that questioned the effectiveness of its antidepressant Paxil in children. After the lawsuit was filed, GSK announced plans to create the Internet-based clinical trial register to provide open access to clinical trial data."
Posted by
Peter Suber at 9/02/2004 01:09:00 PM.
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
I recommend the OA tracking project (OATP) as the best way to stay on top of new OA developments. You can read the OATP feed on a blog-like web page or subscribe to it by RSS, email, or Twitter. You can also help build the feed by tagging new developments you encounter.
